Company: PHAT
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057326
Chunk: 39

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 39
---
 stock directly held by Jennison Associates, LLC, (ii) 423,000 shares of common stock directly held by PGIM, Inc., and (iii) 2,340 shares of common stock directly held by PGIM Quantitative Solutions LLC. The address of Prudential is 751 Broad Street, Newark, NJ 07102.

The amount shown and the following information are derived from Schedule 13G filed by The Carlyle Group Inc. and certain of its affiliates on February 12, 2024. According to the Schedule 13G, these shares consist of (i) 2,061,702 shares of common stock held directly by Abingworth Bioventures 8 LP and (ii) 1,435,106 shares of common stock held directly by Abingworth Bioventures VII LP. The Carlyle Group Inc., which is a publicly traded entity listed on Nasdaq, is the sole shareholder of Carlyle Holdings I GP Inc., which is the sole member of Carlyle Holdings I GP Sub L.L.C., which is the general partner of Carlyle Holdings I L.P., which, with respect to the securities reported herein, is the managing member of CG Subsidiary Holdings L.L.C., which is the managing member of TC Group, L.L.C., which is the managing member of Carlyle Investment Management L.L.C., which is the sole member of Carlyle Genesis UK LLC, which is the principal member of Abingworth LLP. Each of Abingworth Bioventures 8 LP and Abingworth Bioventures VII LP has delegated to Abingworth LLP all investment and dispositive power over the securities held of record by them. Accordingly, each of the foregoing entities may be deemed to share beneficial ownership of the securities held of record by Abingworth Bioventures 8 LP and Abingworth Bioventures VII LP, but each disclaims beneficial ownership of such securities. The address of each of Abingworth LLP, Abingworth Bioventures 8 LP and Abingworth Bioventures VII LP is 38 Jermyn Street, London, SW1Y 6DN, England, United Kingdom. The principal business address of each of the other entities named in this footnote is c/o The Carlyle Group, 1001 Pennsylvania Ave. NW, Suite 220 South, Washington, DC 20004-2505.

Consists of 113,360 shares of common stock issuable to Mr. Cola upon the exercise of options